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Title: Dry needling in the management of myofascial trigger points in the 
orofacial area 
 
Abstract 
Aims: Myofascial pain in the orofacial area is a common cause of head and neck 
pain characterized by the presence of myofascial trigger points (MTrPs). According to 
recent literature, there is a need for well-designed studies concerning dry needling (DN) 
in the management of MTrPs. The objective of our work is to evaluate the effectiveness 
of DN compared to sham DN and counselling in the treatment of active MTrPs in the 
orofacial area. Methods: We conducted a prospective, double-blinded, randomized, 
controlled study in which 30 patients with established MTrPs in the orofacial area were 
randomized into 3 groups. The study group (DN, n=10), the placebo group (sham DN, 
n=10) and the gold standard group (counselling, n=10). Each patient received 3 sessions 
with 7 days intervals. Pain intensity was rated using a visual analogic scale (VAS) and 
unassisted jaw opening without pain (PFJO) was assessed with a millimeter rule after 
each consultation and one month after the last consultation. Results: Patients receiving 
real DN experienced a statistically significant decrease in jaw pain when compared to 
the other groups. PFJO scores increased significantly when compared to sham DN but 
not when compared to counselling which also determined an increase in PFJO. 
Conclusion: A single session of MTrPs DN decreases myofascial pain intensity in 
patients with orofacial MTrPs and also increases PFJO after 3 sessions. These effects 
are sustained during one month. Changes in pain and mandibular range of motion 
support clinically relevant treatment effects. 
 
Key words: Myofascial pain, referred pain, taut band, placebo responses, TMD. 
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Introduction 
Myofascial pain (MP) is characterized by the presence of myofascial trigger points 
(MTrPs), defined as hyperirritable nodules located within a taut band of skeletal 
muscle.1 MP in the orofacial area is a common cause of head and neck pain.2, 3  
Despite insufficient knowledge on pathophysiologic mechanisms of MTrPs4-6 there 
are several therapies for MTrPs that include conservative treatment, such as systemic 
nonsteroidal anti-inflammatory drug (NSAID), local NSAID gel or patch, 
thermotherapy, manual therapy, ultrasound and other physical modalities.6-8 
Additionally, it is important to provide adequate education and home programs to 
patients to avoid recurrent or chronic pain.7 Other techniques like acupuncture, MTrPs 
injections and dry needling (DN) also have been used.6, 7 DN is a commonly used 
procedure and has been object of several studies concerning its efficacy and mechanism 
of action since Lewit’s publication.9-13 
Various studies demonstrated superior effects of DN for treatment of MTrPs in the 
orofacial area when compared to sham DN.14, 15 On the other hand, the placebo effect 
has been consistently reported in the literature and these findings highlight the need for 
sham procedures in studies involving DN.16 Other studies did not report superior effects 
of DN compared to other techniques.17 According to a recent meta-analysis, there is a 
need for well-designed studies concerning DN in the management of MTrPs.18 
The objective of our work is to evaluate the effectiveness of DN (study group) 
compared to sham DN (placebo) and counselling (gold standard)  in the treatment of 
active MTrPs in a sample of patients referred to a temporomandibular disorders (TMD) 
specialized hospital center. 
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The strength of this double-blind RCT is related to the strict technique for 
determination of MTrPs in the orofacial area, the precise place of needle insertion in the 
MTrPs and the way that needle is inserted to eliminate the MTrPs. 
 
Material and methods 
We conducted a prospective, double-blinded, randomized, controlled study in which 
DN, sham DN (placebo) and counselling (gold standard) were compared. 
The study protocol was approved by the Hospital São João Health Ethics Committee. 
Before the study oral and written informed consents were obtained from each 
subject. 
Patients referred to the Stomatology Temporomandibular Disorders (TMD) 
department at the Hospital São João, Oporto Medical School,  were consecutively 
recruited over a period of 7 months and evaluated according to our standard protocol 
with RDC/TMD (axis I and axis II) by a calibrated investigator (CAF).19 Additionally, 
all patients were screened for MTrPs according to Simons and Travell orientations.1, 20 
Patients were included if they had a RDC/TMD axis I diagnostic of myofascial pain 
and active MTrPs in the masseter and/or temporalis muscles. This included (1) localized 
spontaneous pain, (2) presence of a taut, palpable band, (3) localized tenderness in a 
precise point along taut band (4) referred pain area for a given MTrP and (5) replication 
of the patient’s pain symptoms with the referred pain elicited by pressure on MTrP. 
Patients were excluded if they had other TMD diagnostic besides myofascial pain 
(RDC/TMD axis I or axis II), if they had previously received acupuncture, DN or other 
TMD treatment in the last 6 months, if they were under eighteen years old, had a 
bleeding disorder, had needle phobia and if they had rheumatologic, metabolic, 
neurologic or psychiatric disorders.  
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Patients who met these criteria entered the trial. The TMD appointment was 
scheduled according to referral date by Portuguese National Health System. The first 
ten patients were assigned for DN group, the following ten patients were assigned for 
counselling group and the last ten patients were assigned for sham DN. The groups were 
randomized by Random.org. 
In the study group, DN therapy was applied in the MTrPs using standard single use 
sterile acupuncture needles 0,20mm x 13mm. Each patient received 3 sessions with 7 
days intervals. The patient was placed in the supine position, the skin was disinfected 
with alcohol, the trigger points were determined and the needle was inserted. When the 
needle penetrated the MTrP a movement “up and down” was repeated 3 to 5 times 
(without being completely removed). The procedure was repeated for several MTrPs 
(active and latent). 
In the placebo group, sham DN was applied pricking the skin with a blunted needle 
after the skin was disinfected with alcohol and the trigger points determined using the 
same protocol as in the DN group. The sham DN looked very similar to real DN except 
it didn’t penetrate the skin. The procedure is described elsewhere by Streitberger.21 
In the counselling group patients received an educational and counseling program 
about MP and MTrPs including its benign condition and were asked to relax their 
masticatory muscles, not to clench their teeth, not to chew gum, not to bite their nails, 
not to bite pens and to avoid other similar oral habits. 
All groups had 3 sessions for 3 consecutive weeks. The same treatment protocol was 
used in both groups (DN and sham DN). All needlings were performed by the same 
physician experienced in DN (CAF) using the same needles within a constant time 
period. No exercise program and physical therapy modalities were given during the 
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treatment process. All subjects were asked not to take any kind of analgesic, 
nonsteroidal anti-inflammatory or muscle relaxant drugs. 
Pain intensity was rated using a visual analogic scale (VAS).22 Unassisted opening 
without pain (pain-free maximal jaw opening - PFJO) was assessed with a millimeter 
rule.19, 23 Evaluation of patients was carried out before and immediately after the 
treatment (DN, sham DN or counseling) and also one month after the last consultation. 
This evaluation was carried out by a physician who was blinded to the patient´s groups 
(JCP). Patients were not informed about which group they belong to.  
Data was analyzed using IBM SPSS Statistics 21.0. Since the sample had less than 
30 subjects in each group non parametric tests were used. We used the Kruskal-Wallis 
test for comparison between groups (p<0,05). Then we used a Mann-Whitney U test 
corrected for Bonferroni (p<0,05/3) to compare the groups two by two. 
 
Results 
One hundred eighty-one consecutive patients with orofacial pain were screened for 
eligibility criteria between July and December 2013. Finally a total of 30 patients 
satisfied all the criteria and agreed to participate. Figure 1 shows the diagram of 
recruitment of the participants.  
Most of the subjects were female (96,7%, n=29) and the characterization of the 
sample in terms of age is described in table 1.  
Characterization of all groups for VAS and PFJO prior and after the treatment is 
described in table 2 and table 3. 
There were no statistically significant differences between groups with respect to 
VAS (table 4) and PFJO (table 5) scores prior to the treatment. After 3 consultations 
there was a statistically significant difference between the groups with respect to VAS 
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(table 4) and PFJO (table 5) scores and one month after the last consultation we could 
observe a statistically significant difference between the groups with respect to VAS 
(table 4) and PFJO scores (table 5). 
Patients receiving real DN experienced a statistically significant reduction in jaw 
pain when compared to the other groups. Prior to treatment the mean VAS score was 
5,95 and one month after the last DN session VAS score was 0 (table 3). In fact, VAS 
scores decreased in each treatment session and it was statistically significant in every 
observations when compared to sham DN and counselling groups (table 6). Counselling 
and sham DN groups also experienced a decrease in VAS scores. One month after the 
last consultation mean VAS score had decreased from 6,35 to 3,05 for counselling and 
from 6,05 to 4,5 in the sham DN (table 3). This difference was not statistically 
significant between these two groups (table 6). 
Patients receiving real DN experienced an increase in PFJO scores. Mean PFJO prior 
to treatment was 38,4mm and one month after the last DN session the mean PFJO was 
48,2mm (table 2). After the 3rd consultation and one month later mean PFJO scores 
increase was statistically significant when compared to sham DN but not when 
compared to counselling (table 7) which determined an increase in PFJO from mean 
34,8mm to 45,2mm (table 2). No significant increase in PFJO was observed in sham 
DN group. The mean PFJO score prior to treatment was 40,6mm and one month after 
last consultation was 42mm (table 2). There were no statistically significant differences 
in mean PFJO between sham DN and counselling groups in all periods of observation 
(table 7). 
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Discussion 
In our study, we tried to investigate whether DN was superior to sham DN or to a 
conservative modality (counselling) for the treatment of MTrPs in the orofacial area. 
Our results indicates that DN of active and latent MTrPs induced a significant decrease 
in reported pain compared to both sham DN and counselling. These results are 
consistent with other studies showing that DN is effective for treatment of MTrPs.14 
There are also studies which did not report superior effects of DN in comparison to 
other techniques.17 The authors of this study suggested that the improvement in pain 
symptoms was the result of placebo-related factors rather than a true treatment effect. 
Also, in the study of Diracoglu15 both the MTrPs and the control group were needled. In 
our study, to avoid any other noxious stimuli, we used a blunt needle. 
Diracoglu15 found evidence in mean algometric values favoring DN but no difference 
to the controls in terms of VAS and PFJO. In our study, we could observe an increase in 
PFJO in the DN group that was statistically significant when compared with sham DN 
but not when compared to counselling group which also registered an increase in PFJO. 
Our results are in accordance to other studies that conclude that behavioral changes are 
effective in the management of pain in MP patients.24 Our findings were significantly 
better than in the placebo group and although the pain scores have improved in the 
counselling group, the results were significantly better in the DN group. Other authors 
also emphasize the importance of adequate education and home programs in the 
treatment of MTrPs.7 We performed DN and counselling in separate groups to more 
precisely report on the effects of DN.  
In a recent meta-analysis, it was concluded that the effectiveness of DN in the 
management of MTrPs is  limited.18 We believe that these contradictory results might 
be due to difficulty in applying the diagnostic criteria of Simons and Travell to identify 
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MTrPs and also to the user technique for DN. We tried to overcome this challenge by 
using an experienced professional calibrated according to RDC/TMD19 with ten years’ 
experience in identifying MTrPs according to Simons and Travell criteria and DN. 
Despite promising novel applications of ultrasound and magnetic ressonance 
elastography to visualize and characterize MTrPs,25, 26 the Simons and Travell criteria 
have good interexaminer reliability when applied by experienced clinicians.20 Another 
important aspect of our study is that we needled not only active MTrPs but also latent 
MTrPs. Shah developed a technique for measuring the biochemical milieu of human 
skeletal muscle.27 He found higher levels of bioactive substances (inflammatory 
mediators, neuropeptides, catecholamines, and cytokines) not only in the active MTrPs 
but also in the vicinity of active MTrPs.28 Furthermore, these biochemical substances 
were elevated in remote, unaffected muscles of individuals with active MTrPs.29 
In conclusion, this study showed that application of DN into active and latent MTrPs 
in the masseter and temporalis muscles induced significant improvement in pain 
intensity levels and PFJO when compared to sham DN and to counselling in patients 
with MTrPs in the orofacial area. In fact, the results of our RCT indicate that a single 
session of MTrPs DN decreases myofascial pain intensity in patients with orofacial 
MTrPs. After 3 sessions also increases mandibular range of motion in patients with 
orofacial MTrPs. These effects were sustained during one month after the last session of 
DN. The improvement in pain symptoms and mandibular range of motion supports 
clinically relevant treatment effects. 
Nevertheless, the effects of our study were documented in the short term, so future 
studies should include larger samples and explore long-term effect of DN. 
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Figure 1 -  Flow diagram of subjects. 
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• Not meeting inclusion 
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(n=10) 
• Received allocated 
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(n=1) 
Allocated to dry needling 
(n=10) 
• Received allocated 
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Allocated to sham intervention(n=10) 
• Received allocated intervention 
(n=10) 
Final analysis (n=9) 
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(n=0) 
Final analysis (n=8) Final analysis (n=10) 
Inicial analysis (n=10) Inicial analysis (n=10) Inicial analysis (n=10) 
  Table 1 – Sample description in terms of age 
 
 
 
 
Table 2 - Sample description of PFJO (mm) 
Group PFJO - prior to 
treatment 
PFJO - after 1st 
consultation 
PFJO - after 2nd 
consultation 
PFJO - after 3rd 
consultation 
PFJO - one month 
after last consultation 
 
Mean Std Dev Mean Std Dev Mean Std Dev Mean Std Dev Mean Std Dev 
DN 38.40 9.97 43.80 6.65 44.70 7.07 48.11 5.01 48.22 4.58 
C 34.80 11.97 34.80 11.97 39.40 6.80 43.20 4.89 45.20 6.10 
SDN 40.60 7.40 44.10 5.49 42.56 6.25 42.25 3.15 42.00 3.59 
PFJO – pain free maximal jaw opening; DN – dry needling; C – counselling; SDN – sham dry needling 
 
Table 3 – Sample description relative to VAS 
Group VAS - prior to 
treatment 
VAS - after 1st 
consultation 
VAS - after 2nd 
consultation 
VAS - after 3rd 
consultation 
VAS - one month after 
last consultation 
 
Mean Std Dev Mean Std Dev Mean Std Dev Mean Std Dev Mean Std Dev 
DN 5.95 1.38 2.50 2.10 0.30 0.67 0.22 0.67 0.00 0.00 
C 6.35 1.25 6.35 1.25 4.90 1.73 4.30 2.26 3.05 2.79 
SDN 6.05 1.80 5.50 2.12 4.78 1.94 4.50 2.52 4.50 2.52 
VAS – visual analogue scale; DN – dry needling; C – counselling; SDN – sham dry needling 
 
Group Minimum Maximum Mean Std. Deviation 
Dry needling 21 59 33.40 15.25 
Counselling 30 70 41.60 14.26 
Sham dry needling 23 28 24.70 1.70 
Table 4 - Kruskal-Wallis test for comparison between groups for the VAS scores in the different moments of evaluation 
Group VAS - prior to treatment VAS - after 1st consultation VAS - after 2nd consultation VAS - after 3rd consultation VAS - one month after last 
consultation 
 
N Mean 
Rank 
χ
2
 
Sig N Mean 
Rank 
χ
2
 
Sig N Mean 
Rank 
χ
2
 
Sig N Mean 
Rank 
χ
2
 
Sig N Mean 
Rank 
χ
2
 
Sig 
DN 10 14.50  
0.52 
 
ns 
10 7.40  
13.96 
 
0.001 
10 5.65  
18.96 
 
<0.001 
9 5.44  
16.21 
 
<0.001 
9 6.50  
14.76 
 
0.001 SDN 10 14.90 10 17.55 9 19.78 8 18.44 8 20.19 
C 10 17,10 10 21.55 10 20.05 10 18.15 10 15.80 
*ns p>0.05; VAS – visual analogue scale; DN – dry needling; SDN – sham dry needling; C – counselling 
 
Table 5 - Kruskal-Wallis test for comparison between groups for the PFJO scores in the different moments of evaluation 
Group PFJO - prior to 
treatment 
PFJO - after 1st consultation PFJO - after 2nd consultation PFJO - after 3rd consultation PFJO - one month after last 
consultation 
 
N Mean 
Rank 
χ2 Sig N Mean 
Rank 
χ2 Sig N Mean 
Rank 
χ2 Sig N Mean 
Rank 
χ2 Sig N Mean 
Rank 
χ2 Sig 
DN 10 18.25  
3.49 
 
ns 
10 15.90  
0.97 
 
ns 
10 18.75  
3.35 
 
ns 
9 19.50  
6.58 
 
<0.037 
9 18.17  
6.96 
 
0.031 SDN 10 16.90 10 17.20 9 14.28 8 10.75 8 8.19 
C 10 11.35 10 13.40 10 11.90 10 11.65 10 14.90 
*ns p>0.05; PFJO – pain free maximal jaw opening; DN – dry needling; C – counselling; SDN – sham dry needling 
  
Table 6 - Mann-Whitney U test corrected for Bonferroni to compare the groups two by two for VAS scores in the different moments of evaluation 
Group VAS - prior to treatment VAS - after 1st consultation VAS - after 2nd consultation VAS - after 3rd consultation VAS - one month after last 
consultation 
 
N Mean 
Rank 
U Sig N Mean 
Rank 
U Sig N Mean 
Rank 
U Sig N Mean 
Rank 
U Sig N Mean 
Rank 
U Sig 
DN  
Vs  
C 
10 
 
10 
9.50 
 
11.50 
 
40.00 
 
ns 
10 
 
10 
5.95 
 
15.05 
 
4.50 
 
<0.001 
10 
 
10 
5.55 
 
15.45 
 
0.50 
 
<0.001 
9 
 
10 
5.17 
 
14.35 
 
1.50 
 
<0.001 
9 
 
10 
6.50 
 
13.15 
 
13.50 
 
0.008 
DN  
Vs  
SDN 
10 
 
10 
10.50 
 
10.50 
 
50.00 
 
ns 
10 
 
10 
6.95 
 
14.05 
 
14.50 
 
0.005 
10 
 
9 
5.60 
 
14.89 
 
1.00 
 
<0.001 
9 
 
8 
5.28 
 
13.19 
 
2.50 
 
<0.001 
9 
 
8 
5.00 
 
13.50 
 
0.00 
 
<0.001 
C  
Vs  
SDN 
10 
 
10 
11,10 
 
9.90 
 
.00 
 
ns 
10 
 
10 
12.00 
 
9.00 
 
35.00 
 
ns 
10 
 
9 
10.10 
 
9.89 
 
44.00 
 
ns 
10 
 
8 
9.30 
 
9.75 
 
38.00 
 
ns 
10 
 
8 
8.15 
 
11.19 
 
26.50 
 
ns 
*ns p>0.017; VAS – visual analogue scale; DN – dry needling; C – counselling; SDN – sham dry needling 
 
Table 7 - Mann-Whitney U test corrected for Bonferroni to compare the groups two by two for PFJO scores in the different moments of evaluation 
Group PFJO - prior to treatment PFJO - after 1st consultation PFJO - after 2nd consultation PFJO - after 3rd consultation PFJO - one month after last 
consultation 
 
N Mean 
Rank 
U Sig N Mean 
Rank 
U Sig N Mean 
Rank 
U Sig N Mean 
Rank 
U Sig N Mean 
Rank 
U Sig 
DN 
Vs 
C 
10 
 
10 
11.60 
 
9.40 
 
39.00 
 
ns 
10 
 
10 
12.65 
 
8.35 
 
28.50 
 
ns 
10 
 
10 
12.60 
 
8.40 
 
29.00 
 
ns 
9 
 
10 
12.72 
 
7.55 
 
20.50 
 
ns 
9 
 
10 
11.22 
 
8.90 
34.00  
ns 
DN 
Vs 
SDN 
10 
 
10 
9.80 
 
11.20 
 
43.00 
 
ns 
10 
 
10 
11.10 
 
9.90 
 
44.00 
 
ns 
10 
 
9 
11.65 
 
8.17 
 
28.50 
 
ns 
9 
 
8 
11.78 
 
5.88 
 
11.00 
 
0.015 
9 
 
8 
11.94 
 
5,69 
 
9.50 
 
0.008 
C 
Vs 
SDN 
10 
 
10 
9.50 
 
11.50 
 
40.00 
 
ns 
10 
 
10 
8.50 
 
12.50 
 
30.00 
 
ns 
10 
 
9 
9.00 
 
11.11 
 
35.00 
 
ns 
10 
 
8 
9.60 
 
9.38 
 
39.00 
 
ns 
10 
 
8 
11.50 
 
7.00 
 
20.00 
 
ns 
*ns p>0.017; PFJO - pain free maximal jaw opening; DN - dry needling; C - counselling; SDN - sham dry needling 
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